Ireland
--:--IST
Starting soon Not applicable

Effects of a Prehabilitation Program in Patients Undergoing Lumbar Radiculopathy Surgery

NCT06145620 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2025-04
Last updated
2025-02-12

Condition(s) studied

Lumbar Radiculopathy

Investigational drug(s) / intervention(s)

Physiotherapy

Physiotherapy: The intervention involves the visualization of different videos explaining the performance of lumbar strengthening exercises, measures for back care, and neuroscience pain education.

Study summary

The purpose of the following study is to analyze the effects of a prehabilitation program based on therapeutic exercise, back care education and pain neuroscience education through the visualization of videos, compared to standardized written therapeutic exercise in patients undergoing lumbar radiculopathy surgery.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * Adults aged 18 years or older, diagnosed with lumbar radiculopathy, and scheduled for surgery. The symptoms will be predominantly leg pain with or without neurological deficit, with surgical decompression justified. Exclusion Criteria: * Patients currently receiving any other non-pharmacological treatment or physical therapy for the management of lumbar radiculopathy. * Proposed for surgery with instrumentation (e.g., spinal fusion, arthrodesis). * Suffering from a chronic pain-related condition (e.g., fibromyalgia, chronic fatigue syndrome). * Symptoms of spinal cord compression. * Diagnosed with a malignant tumor. * Mental illness. * Previously undergone spinal surgery. * No access to any internet-enabled device.

Primary outcome measure(s)

  • Oswestry Disability Index (ODI) — 4 weeks
    Disability score (0-100). Higher score indicates higher disability.

Trial sites (1)

FacilityCityRegionStatus
Arguisuelas Martinez Maria Dolores Valencia Spain
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06145620 on ClinicalTrials.gov ↗ ← All trials in Spain